Additionally, Lin et al. (2012) have showed that the level of blood DJ-1 modified by 4-hydroxy-2-nonenal (4-HNE) is significantly decreased in late-stage PD patients, suggesting that 4-HNE modified DJ-1 may potentially be one of the biomarkers of disease severity in the body fluid. Here, PARK7 is linked to Parkinson disease.